Quintiles Transnational Holdings Inc (NYSE:Q) target price raised to $94.00, reported today by Goldman Sachs Group Inc.
- Updated: October 9, 2016
Having a price of $78.79, Quintiles Transnational Holdings Inc (NYSE:Q) traded 0.24% higher on the day. With the last close up 11.40% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Quintiles Transnational Holdings Inc has recorded a 50-day average of $77.86 and a two hundred day average of $71.33. Volume of trade was up over the average, with 1,348,221 shares of Q changing hands over the typical 1,114,610
Quintiles Transnational Holdings Inc (NYSE:Q) had its target price raised to $94.00 by Goldman Sachs Group Inc. in a report released 10/05/2016. The upped price target suggests a potential upside of 0.19% from the company's most recent close.
With a total market value of $0, Quintiles Transnational Holdings Inc has price-earnings ratio of 23.89 with a one year low of $55.01 and a one year high of $81.45 .
A total of 15 analysts have released a report on Quintiles Transnational Holdings Inc. Eight analysts rating the company a strong buy, nine equity analysts rating the company a buy, two equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $76.50.
More About Quintiles Transnational Holdings Inc (NYSE:Q)
Quintiles IMS Holdings Inc, formerly Quintiles Transnational Holdings Inc., is a provider of biopharmaceutical development services and commercial outsourcing services. It is engaged in the development and commercialization of pharmaceutical therapies. Its segments include Product Development and Integrated Healthcare Services. Its Product Development segment is a contract research organization and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. The Integrated Healthcare Services segment includes commercial pharmaceutical sales and service organizations, and provides services, including commercial services, such as contract pharmaceutical sales forces, and healthcare business services for the healthcare sector, such as phase research, market access and consulting, health information analytics and technology consulting, and other healthcare solutions.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.